TechNation: Mylan Expected to Invest $20 Million in Drug Developer Mapi

Israeli workers vulnerable to automation at average rates ■ Armis raises $30 million for internet of things security

TheMarker
Send in e-mailSend in e-mail
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. Credit: Jim Bourg, Reuters

Comments